DanCann Pharma A/S issues warrants to the Board of Directors
COPENHAGEN, Denmark, 28 April 2021 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) hereby today announces that DanCann Pharma has issued 300,000 warrants to the Board of Directors in DanCann Pharma with a subscription rate of DKK 3.8993.The warrants program is dedicated for allocation to Company’s Board of Directors, whereby they have the opportunity of participating in a value growth in the Company’s shares. This is expected to lead to an increase in interest in the Company’s development - such as the pricing trends in Company’s shares price - and that continued